Emerging therapeutic targets in caspase-dependent disease

Expert Opinion on Therapeutic Targets

Volumn 3, Issue 3, 1999, Pages 391-411

  McBride, Christopher B ^a   McPhail, Lowell T ^a   Steeves, John D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

apoptosis; autoimmune disease; bcl 2; cancer; caspase; caspase induction; caspase inhibition; cell death; cysteine protease; degenerative disorders; inflammation; inhibitors of apoptosis protein; neurodegeneration; neurotrauma; stroke

Indexed keywords

EID: 0001488060     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.3.3.391     Document Type: Review

References (173)

1. SALVESEN GS, DIXIT VM: Caspases: intracellular signaling by proteolysis. Cell (1997) 91(4):443-446. (Pubitemid 27508233)
2. COHEN GM: Caspases: the executioners of apoptosis. Biochem. J. (1997) 326(1):1-16. (Pubitemid 27386911)
3. THORNBERRY NA, LAZEBNIK Y: Caspases: enemies within. Science (1998) 281(5381):1312-1316. (Pubitemid 28406817)
4. BOONMAN Z, ISACSON O: Apoptosis in neural development and transplantation: role of caspases and trophic factors. Exp. Neurol. (1999) 156:1-15. (Pubitemid 29152979)
5. HELT C, HOERING G, SANDERS L et al.: Effects of caspase inhibitor Bos-Asp-CH2F on fetal ventral mesencephalic transplants. 28th Annual Meeting of the Society for Neuroscience. Los Angeles, CA, USA (1998):1056.
6. SCHIERLE GS, HANSSON O, LEIST M et al.: Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nature Med. (1999) 5(1):97-100. (Pubitemid 29051005)
7. OSHAKO S, ELKON KB: Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis. Cell Death Differ. (1999) 6:13-21. (Pubitemid 29051850)
8. MITRA D, KIM J, MACLOW C, KARSAN A, LAURENCE J: Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies. Am. J. Hemat. (1998) 59(4):279-287. (Pubitemid 28543616)
9. NAGATA S, GOLSTEIN P: The Fas death receptor. Science (1995) 267:1449-1456.
10. ROSEN A, CASCIOLA-ROSEN L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. (1999) 6:6-12. (Pubitemid 29051849)
11. THOMPSON CB: Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267(5203): 1456-1462.
12. EVAN G, LITTLEWOOD T: A matter of life and death. Science (1998) 281:1317-1322.
13. ADAMS JM, CORY S: The Bcl-2 protein family: arbiters of cell survival. Science (1998) 281:1322-1326. (Pubitemid 28406819)
14. WYLLIE AH: Apoptosis and carcinogenesis. Eur. J. Cell Biol. (1997) 73(3):189-197. (Pubitemid 27309753)
15. KIM TW, PETTINGELL WH, JUNG YK, KOVACS DM, TANZI RE: Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science (1997) 277(5324):373-376. (Pubitemid 27450710)
16. BARNES NY, LI L, YOSHIKAWA K et al.: Increased production of amyloid precursor protein provides a substrate for caspase-3 in dying motoneurons. J. Neurosci. (1998) 18(15):5869-5880. (Pubitemid 28341363)
17. WALTER J, SCHINDZIELORZ A, GRUNBERG J, HAASS C: Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl. Acad. Sci. USA (1999) 96(4):1391-1396. (Pubitemid 29098461)
18. GERVAIS FG, XU D, ROBERTSON GS et al.: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic Abeta peptide formation. Cell (1999) 97:395-406.
19. DODEL RC, DU YS, BALES KR et al.: Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Mol. Brain Res. (1999) 64(1):141-148. (Pubitemid 29049246)
20. TAKAI N, NAKANISHI H, TANABE K et al.: Involvement of caspase-like proteinases in apoptosis of neuronal Pc12 cells and primary cultured microglia induced by 6-Hydroxydopamine. J. Neurosci. Res. (1998) 54(2):214-222. (Pubitemid 28469062)
21. GOLDBERG YP, NICHOLSON DW, RASPER DM et al.: Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Gen. (1996) 13(4):442-449. (Pubitemid 26256618)
22. WELLINGTON CL, ELLERBY LM, HACKAM AS et al.: Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. (1998) 273(15):9158-9167. (Pubitemid 28176206)
23. SANCHEZ I, XU C-J, JUO P et al.: Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron (1999) 22:623-633. (Pubitemid 29159860)
24. PERUTZ MF: Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. (1999) 24(2):58-63. (Pubitemid 29346574)
25. KIM M, LEE H-S, LAFORET G et al.: Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. (1999) 19(3):964-973. (Pubitemid 29066159)
26. KRUMAN II, NATH A, MATTSON MP: HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. (1998) 154(2):276-288. (Pubitemid 29044201)
27. PASINELLI P, BORCHELT DR, HOUSEWEART MK, CLEVELAND DW, BROWN RH: Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA (1998) 95(26):15763-15768. (Pubitemid 29018774)
28. HARA H, FRIEDLANDER RM, GAGLIARDINI V et al.: Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA (1997) 94(5):2007-2012. (Pubitemid 27113952)
29. NAMURA S, ZHU J, FINK K et al.: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. (1998) 18(10):3659-3668. (Pubitemid 28225674)
30. CHEN J, NAGAYAMA T, JIN K et al.: Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. (1998) 18(13):4914-4928. (Pubitemid 28285400)
31. ENDRES M, NAMURA S, SHIMIZU-SASAMATA M et al.: Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. (1998) 18(3):238-247. (Pubitemid 28103631)
32. MA J, ENDRES M, MOSKOWITZ MA: Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischemia in mice. Brit. J. Pharm. (1998) 124:756-762. (Pubitemid 28276813)
33. SCHULZ JB, WELLER M, MATTHEWS RT et al.: Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histoxic hypoxia. Cell Death Differ. (1998) 5:847-857. (Pubitemid 28484395)
34. SCHULZ JB, WELLER M, MOSKOWITZ MA: Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. (1999) 45:421-429. (Pubitemid 29165807)
35. YAKOVLEV AG, KNOBLACH SM, FAN L et al.: Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. (1997) 17(19):7415-7424. (Pubitemid 27413272)
36. KERMER P, KLOCKER N, LABES M, BAHR M: Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J. Neurosci. (1998) 18(12):4656-4662. (Pubitemid 28280174)
37. CHAUDHARY P, AHMED F, QUEBADA P, SHARMA SC: Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Mol. Brain Res. (1999) 67:36-45. (Pubitemid 29170066)
38. CROWE MJ, BRESNAHAN JC, SHUMAN SL, MASTERS JN, BEATTIE MS: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys [published erratum appears in Nature Med. 1997 3(2):240]. Nature Med. (1997) 3(1):73-76. (Pubitemid 27019144)
39. SHUMAN SL, BRESNAHAN JC, BEATTIE MS: Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. (1997) 50(5):798-808. (Pubitemid 27518276)
40. KATOH K, IKATA T, KATOH S et al.: Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci. Lett. (1996) 216(1):9-12. (Pubitemid 26321037)
41. EMERY E, ALDANA P, BUNGE MB et al.: Apoptosis after traumatic human spinal cord injury. J. Neurosurg. (1998) 89(6):911-920. (Pubitemid 28544043)
42. YONG C, ARNOLD PM, ZOUBINE MN et al.: Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J. Neurotrauma (1998) 15(7):459-472. (Pubitemid 28313405)
43. MCBRIDE CB, BORISOFF JF, STEEVES JDS: Inhibition of axotomy-induced glial cell death in the developing chick spinal cord. 27th Annual Meeting of the Society for Neuroscience. New Orleans, LA, USA (1997). 777.17.
44. HISAHARA S, SHOJI S, OKANO H, MIURA M: ICE/ced-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. (1997) 69(1):10-20. (Pubitemid 27274151)
45. D'SOUZA SD, BONETTI B, BALASINGAM V et al.: Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. (1996) 184(6):2361-2370. (Pubitemid 27023735)
46. BONETTI B, RAINE CS: Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. (1997) 42(1):74-84. (Pubitemid 27304783)
47. SEKINE C, YAGITA H, KOBATA T et al.: Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem. Biophys. Res. Comm.(1996) 228(1):14-20. (Pubitemid 26390625)
48. KOBAYASHI K, HATANO M, OTAKI M, OGASAWARA T, TOKUHISA T: Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc. Natl. Acad. Sci. USA (1999) 96(4):1457-1462. (Pubitemid 29098472)
49. STENNICKE HR, JURGENSMEIER JM, SHIN H et al.: Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. (1998) 273(42):27084-27090. (Pubitemid 28500413)
50. JANICKE RU, SPRENGART ML, WATI MR, PORTER AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. (1998) 273(16):9357-9360. (Pubitemid 28183012)
51. GREEN DR, REED JC: Mitochondria and apoptosis. Science (1998) 281(5381):1309-1312. (Pubitemid 28406816)
52. REED JC: Double identity for proteins of the Bcl-2 Family. Nature (1997) 387(6635):773-776. (Pubitemid 27270895)
53. KROEMER G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. (1997) 3(6):614-620. (Pubitemid 27264969)
54. FARROW SN, BROWN R: New members of the Bcl-2 family and their protein partners. Curr. Biol. (1996) 6:45-49.
55. MCCARTHY NJ, WHYTE MK, GILBERT CS, EVAN GI: Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. (1997) 136(1):215-227. (Pubitemid 27044816)
56. YUAN J, SHAHAM S, LEDOUX S, ELLIS HM, HORVITZ HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell (1993) 75(4):641-652. (Pubitemid 23346363)
57. KUMAR S, COLUSSI PA: Prodomains-adaptors-oligomerization: the pursuit of caspase activation in apoptosis. Trends Biochem. Sci. (1999) 24:1-4. (Pubitemid 29074453)
58. WILSON, KP, BLACK, JA, THOMSON, JA et al.: Structure and mechanism of interleukin-1 beta converting enzyme. Nature (1994) 370(6487):270-275.
59. MAO PL, JIANG Y, WEE BY, PORTER AG: Activation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomain. J. Biol. Chem. (1998) 273(37):23621-23624. (Pubitemid 28435685)
60. COLUSSI PA, HARVEY NL, KUMAR S: Prodomaindependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J. Biol. Chem. (1998) 273(38):24535-24542. (Pubitemid 28454949)
61. COLUSSI PA, HARVEY NL, SHEARWIN-WHYATT LM, KUMAR S: Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J. Biol. Chem. (1998) 273(41):26566-26570. (Pubitemid 28471667)
62. MUZIO M, STOCKWELL BR, STENNICKE HR, SALVESEN GS, DIXIT VM: An induced proximity model for caspase-8 activation. J. Biol. Chem. (1998) 273(5):2926-2930. (Pubitemid 28133943)
63. YANG X, CHANG HY, BALTIMORE D: Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell (1998) 1(2):319-325. (Pubitemid 128378672)
64. THORNBERRY NA, RANON TA, PIETERSON EP et al.: A combinatorial approach defines specificities of members of the caspase family and granzyme b-functional relationships established for key mediators of apoptosis. J. Biol. Chem. (1997) 272(29):17907-17911. (Pubitemid 27306365)
65. IMAI Y, KIMURA T, MURAKAMI A et al.: The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature (1999) 398:777-785.
66. KISCHKEL FC, HELLBARDT S, BEHRMANN I et al.: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. (1995) 14(22):5579-5588.
67. LI H, YUAN J: Deciphering the pathways of life and death. Curr. Opin. Cell Biol. (1999) 11:261-266. (Pubitemid 29164043)
68. EBERSTADT M, HUANG B, CHEN Z et al.: NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature (1998) 392:941-945. (Pubitemid 28232068)
69. CHOU JJ, MATSUO H, DUAN H, WAGNER G: Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell (1998) 94:171-180. (Pubitemid 28348005)
70. NAKAGAWARA A, NAKAMURA Y, IKEDA H et al.: High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res. (1997) 57(20):4578-4584. (Pubitemid 27441064)
71. SUSIN SA, LORENZO HK, ZAMZAMI N et al.: Mitochondrial release of caspase-2 and-9 during the apoptotic process. J. Exp. Med. (1999) 189(2):381-394.
72. MANCINI M, NICHOLSON DW, ROY S et al.: The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. (1998) 140(6):1485-1495. (Pubitemid 28152996)
73. KRAJEWSKI S, KRAJEWSKA M, ELLERBY LM et al.: Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA (1999) 96:5752-5757. (Pubitemid 29234690)
74. CHANDLER JM, COHEN GM, MACFARLANE M: Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. (1998) 273(18):10815-10818. (Pubitemid 28204912)
75. STROH C, SCHULZE-OSTHOFF K: Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Different. (1998) 5(12):997-1000. (Pubitemid 29008212)
76. PORTER AG, NG P, JANICKE RU: Death substrates come alive. BioEssays (1997) 19(6):501-507. (Pubitemid 27299498)
77. CERRETTI DP, KOZLOSKY CJ, MOSLEY B et al.: Molecular cloning of the interleukin-1 beta converting enzyme. Science (1992) 256(5053):97-100.
78. THORNBERRY NA, BULL HG, CALAYCAY JR et al.: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 356(6372):768-774.
79. GU Y, KUIDA K, TSUTSUI H et al.: Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science (1997) 275(5297):206-209. (Pubitemid 27034760)
80. GHAYUR T, BANERJEE S, HUGUNIN M et al.: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (1997) 386(6625):619-623. (Pubitemid 27175429)
81. DINARELLO CA, NOVICK D, PUREN AJ et al.: Overview of interleukin-18: more than an interferon-gamma inducing factor. J. Leuk. Biol. (1998) 63(6):658-664. (Pubitemid 28274825)
82. CHENG EH, KIRSCH DG, CLEM RJ et al.: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science (1997) 278(5345):1966-1968. (Pubitemid 28013242)
83. CLEM RJ, CHENG EH, KARP CL et al.: Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA (1998) 95(2):554-559.
84. GRANDGIRARD D, STUDER E, MONNEY L et al.: Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. (1998) 17(5):1268-1278. (Pubitemid 28105506)
85. LI H, ZHU H, XU CJ, YUAN J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 94(4):491-501. (Pubitemid 28391865)
86. SAKAHIRA H, ENARI M, NAGATA S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature (1998) 391(6662):96-99. (Pubitemid 28079223)
87. LOETSCHER H, DEUSCHLE U, BROCKHAUS M et al.: Presenilins are processed by caspase-type proteases. J. Biol. Chem. (1997) 272(33):20655-20659. (Pubitemid 27355627)
88. ZOU H, HENZEL WJ, LIU XS, LUTSCHG A, WANG XD: Apaf-1, a human protein homologous to C-Elegans Ced-4, participates in Cytochrome C-dependent activation of Caspase-3. Cell (1997) 90(3):405-413. (Pubitemid 27347231)
89. SRINIVASULA SM, FERNANDES-ALNEMRI AM, ALNEMRI ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell (1998) 1:949-957. (Pubitemid 128379256)
90. HAKEM R, HAKEM A, DUNCAN GS et al.: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 94(3):339-352. (Pubitemid 28376078)
91. YAN M, LEE J, SCHILBACH S, GODDARD A, DIXIT V: mE10, a novel caspase recruitment domaincontaining proapoptotic molecule. J. Biol. Chem. (1999) 274(15):10287-10289.
92. INOHARA N, KOSEKI T, DEL PESO L et al.: Nod1, and apaf-1-like activator of caspase-9 and nuclear factorkappaB. J. Biol. Chem. (1999) 274(21):14560-14567.
93. CARDONE MH, ROY N, STENNICKE HR et al.: Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 282(5392):1318-1321. (Pubitemid 28524494)
94. YANG X, STENNICKE HR, WANG B et al.: Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and-7. J. Biol. Chem. (1998) 273(51):34278-34283. (Pubitemid 29008904)
95. SLEE EA, HARTE MT, KLUCK RM et al.: Ordering the Cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner. J. Cell Biol. (1999) 144(2):281-292. (Pubitemid 29066031)
96. WANG S, MIURA M, JUNG YK et al.: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell (1998) 92(4):501-509. (Pubitemid 28101113)
97. CLEM RJ, MILLER LK: Control of programmed cell death by the Baculovirus genes p35 and IAP. Mol. Cell. Biol. (1994) 14(8):5212-5222. (Pubitemid 24235949)
98. RAY CA, BLACK RA, KRONHEIM SR et al.: Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell (1992) 69(4):597-604.
99. QUAN LT, CAPUTO A, BLEACKLEY RC, PICKUP DJ, SALVESEN GS: Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. (1995) 270(18):10377-10379.
100. ZHOU Q, SNIPAS S, ORTH K et al.: Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. (1997) 272(12):7797-7800. (Pubitemid 27137336)
101. EKERT PG, SILKE J, VAUX DL: Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors. EMBO J. (1999) 18(2):330-338. (Pubitemid 29041942)
102. GAGLIARDINI V, FERNANDEZ PA, LEE RK et al.: Prevention of vertebrate neuronal death by the crmA gene [published erratum appears in Science 1994 264(5164):1388]. Science (1994) 263(5148):826-828.
103. TINHOFER I, MARSCHITZ I, KOS M et al.: Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand + tumor cells in B chronic lymphocytic leukemia. Blood (1998) 91(11):4273-4281. (Pubitemid 28261992)
104. IRMLER M, THOME M, HAHNE M et al.: Inhibition of death receptor signals by cellular FLIP. Nature (1997) 388(6638):190-195. (Pubitemid 27297457)
105. THOME M, SCHNEIDER P, HOFMANN K et al.: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 386(6624):517-521. (Pubitemid 27164081)
106. BERTIN J, ARMSTRONG RC, OTTILIE S et al.: Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA (1997) 94(4):1172-1176. (Pubitemid 27087823)
107. HU S, VINCENZ C, BULLER M, DIXIT VM: A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. (1997) 272(15):9621-9624. (Pubitemid 27171619)
108. MUZIO M, CHINNAIYAN AM, KISCHKEL FC et al.: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell (1996) 85(6):817-827. (Pubitemid 26193033)
109. BOLDIN MP, GONCHAROV TM, GOLTSEV YV, WALLACH D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell (1996) 85(6):803-815.
110. RASPER D, VAILLANCOURT J, HADANO S: Cell death attenuation by 'Usurpin' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD95 (Fas/Apo-1) receptor complex. Cell Death Differ. (1998) 5:271-288. (Pubitemid 28356540)
111. LACASSE EC, BAIRD S, KORNELUK RG, MACKENZIE AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene (1998) 17:3247-3259. (Pubitemid 29043977)
112. DEVERAUX QL, REED TC: IAP family proteins-suppressors of apoptosis. Genes Devel. (1999) 13(3):239-252.
113. BIRNBAUM MJ, CLEM RJ, MILLER LK: An apoptosisinhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J. Virol. (1994) 68(4):2521-2528. (Pubitemid 24091932)
114. CLEM RJ, FECHHEIMER M, MILLER LK: Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science (1991) 254(5036):1388-1390. (Pubitemid 21917477)
115. CROOK NE, CLEM RJ, MILLER LK: An apoptosisinhibiting baculovirus gene with a zinc finger-like motif. J. Virol. (1993) 67(4):2168-2174. (Pubitemid 23088392)
116. HAY BA, WASSARMAN DA, RUBIN GM: Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell (1995) 83(7):1253-1262. (Pubitemid 26007815)
117. KAMITA SG, MAJIMA K, MAEDA S: Identification and characterization of the p35 gene of Bombyx mori nuclear polyhedrosis virus that prevents virusinduced apoptosis. J. Virol. (1993) 67(1):455-463. (Pubitemid 23003009)
118. SUGIMOTO A, FRIESEN PD, ROTHMAN JH: Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J. (1994) 13(9):2023-2028. (Pubitemid 24139713)
119. RABIZADEH S, LACOUNT DJ, FRIESEN PD, BREDESEN DE: Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J. Neurochem. (1993) 61(6):2318-2321. (Pubitemid 23354096)
120. BUMP NJ, HACKETT M, HUGUNIN M et al.: Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 269(5232):1885-1888.
121. FISHER AJ, DELA CRUZ W, ZOOG SJ, SCHNEIDER CL, FRIESEN PD: Crystal structure of baculovirus p35: role of novel reactive site loop in apoptotic caspase inhibition. EMBO (1999) 18(8):2031-2039. (Pubitemid 29179160)
122. QI XM, HE H, ZHONG H, DISTELHORST CW: Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells. Oncogene (1997) 15(10):1207-1212. (Pubitemid 27429624)
123. ROY N, DEVERAUX QL, TAKAHASHI R, SALVESEN GS, REED JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. (1997) 16(23):6914-6925. (Pubitemid 27520792)
124. LOVERING R, HANSON IM, BORDEN KL et al.: Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl. Acad. Sci. USA (1993) 90(6):2112-2116. (Pubitemid 23078575)
125. FREEMONT PS, HANSON IM, TROWSDALE J: A novel cysteine-rich sequence motif. Cell (1991) 64(3):483-484.
126. HOFMANN K, BUCHER P, TSCHOPP J: The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. (1997) 22(5):155-156. (Pubitemid 27199314)
127. ROY N, MAHADEVAN MS, MCLEAN M et al.: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 80(1):167-178.
128. ROTHE M, PAN MG, HENZEL WJ, AYRES TM, GOEDDEL DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell (1995) 83(7):1243-1252. (Pubitemid 26007814)
129. LISTON P, ROY N, TAMAI K et al.: Suppression of apoptosis in mammalian cells by Naip and a related family of Iap genes. Nature (1996) 379(6563):349-353. (Pubitemid 26033078)
130. UREN AG, PAKUSCH M, HAWKINS CJ, PULS KL, VAUX DL: Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA (1996) 93(10):4974-4978.
131. AMBROSINI G, ADIDA C, ALTIERI DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. (1997) 3(8):917-921. (Pubitemid 27353455)
132. HAUSER HP, BARDROFF M, PYROWOLAKIS G, JENTSCH S: A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J. Cell Biol. (1998) 141(6):1415-1422. (Pubitemid 28289916)
133. DEVERAUX QL, TAKAHASHI R, SALVESEN GS, REED JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 388(6639):300-304. (Pubitemid 27317977)
134. DEVERAUX QL, ROY N, STENNICKE HR et al.: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. (1998) 17(8):2215-2223. (Pubitemid 28171907)
135. BARINAGA M: Forging a path to cell death [published erratum appears in Science 1996 274(5291):1289]. Science (1996) 273(5276):735-737.
136. XU DG, CROCKER SJ, DOUCET JP et al.: Elevation of neuronal expression of Naip reduces ischemic damage in the rat hippocampus. Nature Med. (1997) 3(9):997-1004. (Pubitemid 27391954)
137. TAMM I, WANG Y, SAUSVILLE E et al.: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. (1998) 58(23):5315-5320. (Pubitemid 28551107)
138. ADIDA C, BERREBI D, PEUCHMAUR M, REYES-MUGICA M, ALTIERI DC: Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet (1998) 351(9106):882-883. (Pubitemid 28121185)
139. LU CD, ALTIERI DC, TANIGAWA N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. (1998) 58(9):1808-1812. (Pubitemid 28217451)
140. KAWASAKI H, ALTIERI DC, LU CD et al.: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. (1998) 58(22):5071-5074. (Pubitemid 28521163)
141. TALANIAN RV, QUINLAN C, TRAUTZ S et al.: Substrate specificities of caspase family proteases. J. Biol. Chem. (1997) 272(15):9677-9682. (Pubitemid 27171628)
142. THORNBERRY NA, MOLINEAUX SM: Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Prot. Sci. (1995) 4(1):3-12.
143. SLEE EA, ZHU HJ, CHOW SC et al.: Benzyloxycarbonyl-Val-Ala-Asp (Ome) fluoromethylketone (Z-Vad.Fmk) inhibits apoptosis by blocking the processing of Cpp32. Biochem. J. (1996) 315(1):21-24. (Pubitemid 26113530)
144. LIVINGSTON DJ: In vitro and in vivo studies of ICE inhibitors. J. Cell. Biochem. (1997) 64(1):19-26. (Pubitemid 27081791)
145. MILLIGAN CE, PREVETTE D, YAGINUMA H et al.: Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron (1995) 15(2):385-393.
146. RODRIGUEZ I, MATSUURA K, ODY C, NAGATA S, VASSALLI P: Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. (1996) 184(5):2067-2072. (Pubitemid 26404500)
147. CHENG Y, DESHMUKH M, D'COSTA A et al.: Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxicischemic brain injury. J. Clin. Invest. (1998) 101(9):1992-1999. (Pubitemid 28226119)
148. KAUSHAL GP, SINGH AB, SHAH SV: Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am. J. Physiol. (1998) 274(3 Pt 2):F587-595.
149. CHOI DW: Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. (1996) 6(5):667-672. (Pubitemid 26387723)
150. GOTTLIEB RA, BURLESON KO, KLONER RA, BABIOR BM, ENGLER RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. (1994) 94(4):1621-1628. (Pubitemid 24309885)
151. AKIYAMA K, GLUCKMAN TL, TERHAKOPIAN A et al.: Apoptosis in experimental myocardial infarction in situ and in the perfused heart in vitro. Tissue Cell (1997) 29(6):733-743. (Pubitemid 28040838)
152. KOGLIN J, GRANVILLE DJ, GLYSING-JENSEN T et al.: Attenuated acute cardiac rejection in NOS2-/-recipients correlates with reduced apoptosis. Circulation (1999) 99(6):836-842. (Pubitemid 29083027)
153. VOCERO-AKBANI AM, HEYDEN NV, LISSY NA, RATNER L, DOWDY SF: Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nature Med. (1999) 5(1):29-33. (Pubitemid 29050995)
154. BUCKLEY CD, PILLING D, HENRIQUEZ NV et al.: RGD peptides induce apoptosis by direct caspase-3 activation. Nature (1999) 397(6719):534-539.
155. ASHKENAZI A, DIXIT VM: Death receptors: signaling and modulation. Science (1998) 281(5381):1305-1308. (Pubitemid 28406815)
156. SHERIDAN JP, MARSTERS SA, PITTI RM et al.: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 277(5327):818-821. (Pubitemid 27366733)
157. CLARKE PG: Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. (1990) 181(3):195-213. (Pubitemid 20153523)
158. PORTERA-CAILLIAU C, PRICE DL, MARTIN LJ: Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. (1997) 378(1):88-104. (Pubitemid 27057533)
159. PORTERA-CAILLIAU C, PRICE DL, MARTIN LJ: Excitotoxic neuronal death in the immature brain is an apoptosisnecrosis morphological continuum. J. Comp. Neurol. (1997) 378(1):70-87. (Pubitemid 27057532)
160. MEY J , THANOS S: Intravitreal injections of neurotrophic factors support
161. MANSOUR-ROBAEY S, CLARKE DB, WANG YC, BRAY GM, AGUAYO AJ: Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. USA (1994) 91(5):1632-1636. (Pubitemid 24080259)
162. FEHLINGS MG, TATOR CH: The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. (1995) 132:220-228.
163. VEGGEBERG S: Blocking apoptotic damage after a heart attack. Mol. Med. Today (1998) 4(7):278. (Pubitemid 28364102)
164. MASTRANGELO AJ, BETENBAUGH MJ: Overcoming apoptosis: new methods for improving proteinexpression systems. Trends Biotechnol. (1998) 16(2):88-95. (Pubitemid 28055478)
165. DICKSON AJ: Apoptosis regulation and its applications to biotechnology. Trends Biotech. (1998) 16(8):339-342. (Pubitemid 28361836)
166. FERNANDES-ALNEMRI T, ARMSTRONG RC, KREBS J et al.: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA (1996) 93(15):7464-7469. (Pubitemid 26277057)
167. SRINIVASULA SM, FERNANDES-ALNEMRI T, ZANGRILLI J et al.: The Ced-3/interleukin 1beta converting enzymelike homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J. Biol. Chem. (1996) 271(43):27099-27106. (Pubitemid 26359130)
168. SEOL DW, BILLIAR TR: A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. (1999) 274(4):2072-2076.
169. SRINIVASULA SM, AHMAD M, GUO Y et al.: Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res. (1999) 59(5):999-1002. (Pubitemid 29135957)
170. TAKAHASHI A, ALNEMRI ES, LAZEBNIK YA et al.: Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA (1996) 93(16):8395-8400.
171. ORTH K, CHINNAIYAN AM, GARG M, FROELICH CJ, DIXIT VM: The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. (1996) 271(28):16443-16446. (Pubitemid 26238991)
172. WALKER NP, TALANIAN RV, BRADY KD et al.: Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell (1994) 78(2):343-352. (Pubitemid 24241101)
173. ROTONDA J, NICHOLSON DW, FAZIL KM et al.: The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. (1996) 3(7):619-625. (Pubitemid 26239210)